Viral serpin, Serp-1, inhibits endogenous angiogenesis in the chicken chorioallantoic membrane model

Mary Richardson, Liying Liu, Lauren Dunphy, David Wong, Yunming Sun, Kasinath Viswanathan, Gurmit Singh, Alexandra Lucas

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


Background: Angiogenesis is a critical factor in the development of malignant tumors, in arthritic joints, and in cardiovascular disease. In cardiovascular disease, angiogenesis is recognised both as a potential therapy and as a complicating factor in atherosclerotic plaque rupture and thrombotic obstruction. Serine proteases regulate thrombosis, inflammation, and cell invasion, events that trigger various stages of angiogenesis and are in turn regulated by inhibitors, termed serpins. Serp-1 is a secreted anti-inflammatory viral serpin that profoundly inhibits early mononuclear cell invasion, and the development of atherosclerosis, transplant vasculopathy, and arthritis in a range of animal models. Methods: The capacity of Serp-1 to alter angiogenesis was evaluated in the chicken chorioallantoic membrane (CAM) model using morphometric analysis of vascular changes and RT-PCR to explore alterations in gene expression. Results: Serp-1 inhibited endogenous angiogenesis in a dose-dependent manner, with associated altered expression of laminin and vascular endothelial growth factor (VEGF). Serp-1 was ineffective in CAMs no longer in the rapid growth phase. Similar inhibition of angiogenesis was detected after inhibition of VEGF, but not after treatment with the inactivated reactive center loop mutant of Serp-1. Conclusions: The angiogenic process can be controlled using Serp-1, an anti-inflammatory agent that is effective at low concentrations with rapid reversibility, targets endothelial cells, and reduces the availability of VEGF. These properties may be especially important in cardiovascular disease, reducing plaque destabilization. It is likely that the anti-angiogenic activity of Serp-1 contributes to the observed anti-inflammatory and anti-atherogenic actions with potential importance in this therapeutic setting.

Original languageEnglish (US)
Pages (from-to)191-202
Number of pages12
JournalCardiovascular Pathology
Issue number4
StatePublished - Jul 2007
Externally publishedYes


  • Angiogenesis
  • Atherosclerosis
  • CAM
  • Laminin
  • Serine protease
  • Serp-1
  • Serpin
  • VEGF

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Viral serpin, Serp-1, inhibits endogenous angiogenesis in the chicken chorioallantoic membrane model'. Together they form a unique fingerprint.

Cite this